Home Tools
Log in
Cart

Search Result

Search Results for " gw572016 "

4

Compounds

Cat No. Product Name Synonyms Targets
T0078 Lapatinib GSK572016,GW572016 EGFR , Ferroptosis , Autophagy
Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression.
T72577 Lapatinib tosylate GW2016 tosylate,GW572016 tosylate,GW572016 tosylate ; GW2016 tosylate
Lapatinib tosylate (GW572016), a robust and orally administered inhibitor specifically targeting the tyrosine kinase domains of ErbB-2 and EGFR, exhibits inhibitory concentration 50 (IC50) values of 10.2 nM and 9.8 nM ag...
T6235 Lapatinib Ditosylate Lapatinib (GW-572016) Ditosylate,GW-572016 ditosylate,Tykerb ditosylate EGFR , Ferroptosis , Autophagy
Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).
T0078L Lapatinib ditosylate monohydrate Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate,Lapatinib tosilate hydrate,Lapatinib tosilate,Tykerb,Tyverb EGFR , Ferroptosis , Autophagy
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated w...
TargetMol